Protein Polymer launches new orthopaedic company
This article was originally published in Clinica
Protein Polymer Technologies and a venture capital company are to set up Spine Wave, a new company to commercialise Protein Polymer's technology of injectable protein used for spinal disc repair. Its first commercial product is likely to be an effective outpatient treatment for low back pain.
You may also be interested in...
Celltrion has accelerated the development of its antiviral treatment for COVID-19 and aims to launch a rapid self-testing kit that could provide results within 15-20 minutes. The Korean firm also plans to develop a ‘super antibody’ to prepare for potential future pandemic situations.
Paracetamol, acetylcysteine and loperamide among list of OTC drugs deemed "essential" by Spain in the fight against coronavirus.
Mylan, in partnership with Indian firm Lupin, will be looking to rival Biogen and Sandoz by introducing an etanercept biosimilar in European markets following a positive opinion by the EMA’s CHMP on Mylan's application.